- Stocks
- Healthcare
- NYSE: BSX

Price (delayed)

$48.83

Market cap

$70.06B

P/E Ratio

108.51

Dividend/share

N/A

EPS

$0.45

Enterprise value

$78.07B

Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology,

The revenue has increased by 7% YoY

Boston Scientific's gross profit has increased by 7% YoY

The EPS has decreased by 35% YoY but it has increased by 10% from the previous quarter

Boston Scientific's net income has decreased by 33% YoY but it has increased by 7% QoQ

The P/E is 35% above the 5-year quarterly average of 80.6 and 25% above the last 4 quarters average of 87.0

Boston Scientific's debt has increased by 4.1% QoQ

What are the main financial stats of BSX

Market
Valuations
Earnings

Shares outstanding

1.43B

Market cap

$70.06B

Enterprise value

$78.07B

Price to earnings (P/E)

108.51

Price to book (P/B)

3.98

Price to sales (P/S)

5.51

EV/EBIT

48.49

EV/EBITDA

28.43

EV/Sales

6.16

Revenue

$12.68B

EBIT

$1.61B

EBITDA

$2.75B

Free cash flow

$1.02B

Per share
Balance sheet
Liquidity

EPS

$0.45

Free cash flow per share

$0.71

Book value per share

$12.27

Revenue per share

$8.87

TBVPS

$9.54

Total assets

$32.47B

Total liabilities

$14.9B

Debt

$8.94B

Equity

$17.57B

Working capital

$1.96B

Debt to equity

0.51

Current ratio

1.51

Quick ratio

0.76

Net debt/EBITDA

2.92

Margins
Efficiency
Dividend

EBITDA margin

21.7%

Gross margin

68.8%

Net margin

5.5%

Operating margin

13%

Return on assets

2%

Return on equity

3.7%

Return on invested capital

9.1%

Return on capital employed

5.6%

Return on sales

12.7%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Boston Scientific stock price performed over time

Intraday

1.84%

1 week

2.58%

1 month

4.92%

1 year

10.43%

YTD

5.53%

QTD

5.53%

How have Boston Scientific's revenue and profit performed over time

Revenue

$12.68B

Gross profit

$8.73B

Operating income

$1.65B

Net income

$697M

Gross margin

68.8%

Net margin

5.5%

Boston Scientific's net margin has decreased by 37% YoY but it has increased by 6% QoQ

Boston Scientific's operating income has increased by 37% YoY and by 12% from the previous quarter

Boston Scientific's net income has decreased by 33% YoY but it has increased by 7% QoQ

BSX's operating margin is up by 29% year-on-year and by 11% since the previous quarter

What is Boston Scientific's growth rate over time

What is Boston Scientific stock price valuation

P/E

108.51

P/B

3.98

P/S

5.51

EV/EBIT

48.49

EV/EBITDA

28.43

EV/Sales

6.16

The EPS has decreased by 35% YoY but it has increased by 10% from the previous quarter

The P/E is 35% above the 5-year quarterly average of 80.6 and 25% above the last 4 quarters average of 87.0

The stock's price to book (P/B) is 17% more than its last 4 quarters average of 3.4 but 10% less than its 5-year quarterly average of 4.4

The equity has grown by 6% YoY

BSX's P/S is 15% above its last 4 quarters average of 4.8 and 8% above its 5-year quarterly average of 5.1

The revenue has increased by 7% YoY

How efficient is Boston Scientific business performance

The return on equity has declined by 39% year-on-year but it has increased by 6% since the previous quarter

The return on assets has declined by 35% year-on-year but it has grown by 5% since the previous quarter

The ROS has increased by 18% from the previous quarter and by 7% YoY

BSX's ROIC is up by 17% from the previous quarter and by 10% YoY

What is BSX's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for BSX.

How did Boston Scientific financials performed over time

Boston Scientific's total assets is 118% more than its total liabilities

BSX's quick ratio is up by 23% since the previous quarter but it is down by 13% year-on-year

BSX's total liabilities is down by 4.6% year-on-year but it is up by 4.1% since the previous quarter

Boston Scientific's debt is 49% lower than its equity

Boston Scientific's debt to equity has decreased by 7% YoY but it has increased by 4.1% from the previous quarter

The equity has grown by 6% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.